Transaction #2622 · Form 4 · 0001501697-25-000035

X4 Pharmaceuticals, Inc · Purchase · Common Stock

X4 Pharmaceuticals, Inc · Transacted October 23, 2025 · Filed October 27, 2025

Original SEC filing ↗

What does this filing report?

An SEC Form 4 filing for X4 Pharmaceuticals, Inc records a purchase involving Common Stock on October 23, 2025. The reported quantity was 86,206. The filing date is October 27, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Transaction details

Company CIK
0001501697
Security type
Non-derivative
Acquisition type
Purchase · Code P
Quantity acquired
86,206
Reported price
2.9
Reference value
249,997.4
Currency
Currency not specified
Ownership
Direct
Holdings after transaction
376,087
Ownership description
Not reported
SEC acceptance time
Oct 27, 2025, 6:40 PM EDT
10b5-1 indication
Not indicated

Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.

Reporting owners

These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.

Company listings

XFOR · Nasdaq · linked security

The linked listing is identified separately from other current company listings.

Filing footnotes & remarks

F1
Consists of shares of the Issuer's common stock purchased in connection with the Issuer's public offering.

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.

This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.